Spots Global Cancer Trial Database for vincristine sulfate liposome
Every month we try and update this database with for vincristine sulfate liposome cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia | NCT02072785 | Adult Acute Lym... | Vincristine Sul... Vincristine Sul... | 18 Years - 65 Years | Nanjing Luye Sike Pharmaceutical Co., Ltd. | |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | NCT00567567 | Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Isotretinoin Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Thiotepa Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | NCT00379340 | Stage III Kidne... Stage IV Kidney... | 3-Dimensional C... Conventional Su... Cyclophosphamid... Dactinomycin Doxorubicin Hyd... Etoposide Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | NCT02861040 | Recurrent Adult... Refractory Adul... | Laboratory Biom... Pharmacological... Vincristine Sul... Volasertib | 18 Years - | Northwestern University | |
| PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients | NCT04243434 | Hematologic Dis... | Vincristine Sul... CHOP R-CHOP | 18 Years - | Acrotech Biopharma Inc. | |
| Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia | NCT03136146 | Recurrent Acute... Recurrent Adult... Recurrent Burki... Recurrent Burki... Recurrent Child... Recurrent High ... Refractory Acut... Refractory Burk... Refractory Burk... Refractory High... Refractory Lymp... | Bortezomib Clofarabine Cyclophosphamid... Dexamethasone Etoposide Ofatumumab Pegfilgrastim Rituximab Vincristine Sul... | 15 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor | NCT00379340 | Stage III Kidne... Stage IV Kidney... | 3-Dimensional C... Conventional Su... Cyclophosphamid... Dactinomycin Doxorubicin Hyd... Etoposide Vincristine Sul... | - 29 Years | Children's Oncology Group | |
| Volasertib and Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | NCT02861040 | Recurrent Adult... Refractory Adul... | Laboratory Biom... Pharmacological... Vincristine Sul... Volasertib | 18 Years - | Northwestern University | |
| PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients | NCT04243434 | Hematologic Dis... | Vincristine Sul... CHOP R-CHOP | 18 Years - | Acrotech Biopharma Inc. | |
| Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | NCT02337478 | Recurrent Adult... | Vincristine Sul... Laboratory Biom... | 18 Years - | Wake Forest University Health Sciences | |
| Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease | NCT00025259 | Childhood Lymph... Childhood Mixed... Childhood Nodul... Childhood Nodul... Stage I Childho... Stage II Childh... Stage III Child... Stage IV Childh... | Bleomycin Sulfa... Cisplatin Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Etoposide Filgrastim Involved-Field ... Prednisone Vincristine Sul... | - 21 Years | Children's Oncology Group | |
| Phase III Study of Vincristine Sulfate Liposome For Injection In Adults With Naïve Acute Lymphoblastic Leukemia | NCT02072785 | Adult Acute Lym... | Vincristine Sul... Vincristine Sul... | 18 Years - 65 Years | Nanjing Luye Sike Pharmaceutical Co., Ltd. | |
| Comparing Two Different Myeloablation Therapies in Treating Young Patients Who Are Undergoing a Stem Cell Transplant for High-Risk Neuroblastoma | NCT00567567 | Localized Resec... Localized Unres... Recurrent Neuro... Regional Neurob... Stage 4 Neurobl... Stage 4S Neurob... | Autologous Hema... Carboplatin Cisplatin Cyclophosphamid... Doxorubicin Hyd... Etoposide External Beam R... Filgrastim Isotretinoin Laboratory Biom... Melphalan Peripheral Bloo... Pharmacological... Thiotepa Topotecan Hydro... Vincristine Sul... | - 30 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
